Serotonergic modulating drugs for functional gastrointestinal diseases.
about
Slow transit constipation: a review of a colonic functional disorderNeurogenic and myogenic properties of pan-colonic motor patterns and their spatiotemporal organization in rats5-HT₃ antagonists under development.Role of serotonin in the pathophysiology of the irritable bowel syndrome.Chronic idiopathic slow transit constipation: pathophysiology and management.The specialty of colon and rectal surgery: its impact on patient care and role in academic medicine.Methionine enhances the contractile activity of human colon circular smooth muscle in vitroLong-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome.Neuroinflammation in inflammatory bowel disease.American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.Functional Disorders: Slow-Transit Constipation.Treatment functional GI disease: the complex pharmacology of serotonergic drugs.Chronic stress-induced alterations in mouse colonic 5-HT and defecation responses are strain dependent.Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome.
P2860
Q24653627-4FE2D4E9-6539-4342-A451-5F4B5C4106A4Q27330231-E24FD529-5C46-4ADB-BDDE-A27D933E9352Q33719742-52A15CC6-DDBC-48E3-8BE3-4B86CFFE956BQ35047066-E57C3BCF-B75C-411A-9EFF-92A224AF2F0CQ35157513-06D50F23-3274-4D67-B89E-D3CDDDBA4473Q35888416-0FF20E5B-054E-4C5D-9C5A-5FF93BE14AC4Q36079056-08413748-AE49-452D-A159-3DAC37023E1FQ37057059-30D8A321-F0BC-4A5A-B7DC-FA0869A0DEEEQ37771058-8A0E37AD-705C-4A31-B6E2-D9890CF189B6Q38236812-421895C0-E67F-4024-B878-F1913F27B8C5Q39112649-8397B132-2AB2-4820-A366-3893AB8F78EAQ42780042-0098C572-DF5D-4D5C-B21A-55F55DFDAAF4Q43333102-BCC834F3-1073-4569-9F60-18D03522D008Q43336624-1CBE52FA-C71D-4887-BF78-86F65CBA39A7Q47166341-00B2F47E-F03D-4764-BEC0-B8CFD80A2FA6Q51419778-79CEDB37-AD14-4B58-98AF-F772F7314FEEQ51470908-345CF76C-E144-4262-930C-A13582F7B841
P2860
Serotonergic modulating drugs for functional gastrointestinal diseases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Serotonergic modulating drugs for functional gastrointestinal diseases.
@ast
Serotonergic modulating drugs for functional gastrointestinal diseases.
@en
Serotonergic modulating drugs for functional gastrointestinal diseases.
@nl
type
label
Serotonergic modulating drugs for functional gastrointestinal diseases.
@ast
Serotonergic modulating drugs for functional gastrointestinal diseases.
@en
Serotonergic modulating drugs for functional gastrointestinal diseases.
@nl
prefLabel
Serotonergic modulating drugs for functional gastrointestinal diseases.
@ast
Serotonergic modulating drugs for functional gastrointestinal diseases.
@en
Serotonergic modulating drugs for functional gastrointestinal diseases.
@nl
P2860
P1476
Serotonergic modulating drugs for functional gastrointestinal diseases.
@en
P2860
P356
10.1046/J.1365-2125.2002.01612.X
P407
P577
2002-07-01T00:00:00Z